Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 29, 1999 - Issue 8
Submit an article Journal homepage
72
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Metabolism of tauromustine in liver and lung microsomes from various species

H. TUVESSON Pharmacokinetics and Metabolism, Active Biotech Research AB, PO Box 724, S-220 07 Lund, Sweden
,
P. O. GUNNARSSON Pharmacokinetics and Metabolism, Active Biotech Research AB, PO Box 724, S-220 07 Lund, Sweden
&
J. SEIDEGARD Pharmacokinetics and Metabolism, Active Biotech Research AB, PO Box 724, S-220 07 Lund, Sweden
Pages 783-792 | Published online: 22 Sep 2008

References

  • BIBBY, M. C., DOUBLE, J. A. and MORRIS, C. M., 1988, Anti-tumour activity of TCNU in a panel of transplantable murine colon tumours. European Journal of Cancer and Clinical Oncology, 24, 1361–1364.
  • ERNSTER, L., SiErcEvrrz, P. and PALADE, G. E., 1962, Enzyme—structure relationships in the endoplasmic reticulum of rat liver. Journal of Cell Biology, 15, 541–562.
  • HARTLEY -ASP, B., CHRESTENSSON, P. I., GUNNARSSON, K., GUNNARSSON, P. 0., JENSEN, G., POLACEK, J. and STAMVIK, A., 1988, Anti-tumour, toxicological and pharmacokinetic properties of a novel taurin-based nitrosourea (TCNU). Investigational New Drugs, 6, 19–30.
  • HARTLEY -Asp, B., HANSSON, K., VIBE -PETERSEN, J., HANSEN, H. H., POLACEK, J., ELLMAN, M. and GUNNARSSON, P. 0., 1996, Chromosome aberrations and pharmacokinetics in patients receiving tauromustine as either a single or a repeated dose. Cancer Chemotherapy and Pharmacology, 38, 309–316.
  • KOHN, K. W., 1977, Interstrand cross-linking of DNA by 1,3-bis(2-chloro-ethyl)-1-nitrosourca and other 1-(2-haloethyl)-1-nitrosoureas Cancer Research, 37, 1450–1454.
  • LOFTSSON, T. and BALDVINSDO TTIR, J., 1992, Degradation of tauromustine (TCNU) in aqueous solutions Acta Pharmacologica Nordavica, 4, 129–132.
  • LOWRY, 0. H., ROSENBROUGH, N. J., FAR, A. L. and RANDALL, R. L., 1951, Protein measurement with the Folin phenol reagent Journal of Biological Chemistry, 193, 265–275.
  • MATTHEW, A., BIBBY, M. C., DOUBLE, J. A. and CRAWFORD, S. M., 1989, Anti-tumour activity and bone marrow toxicity of the TCNU metabolites LS2724 and LS 2715. Investigational New Drugs, 7, 405.
  • MATTHEW, A. M., CHRISTENSSON, P. I., SEIDEGA RD, J., TUVESSON, H., BIBBY, M. C., HARTLEY -ASP B. and CREAVEN, P. J., 1994, Effect of drug scheduling on the anti-tumour activity and bone marrow toxicity of tauromustine (TCNU). International Journal of Oncology, 4, 403–409.
  • MITCHELL, E. P. and SCHEIN, P. S., 1986, Contributions of nitrosoureas to cancer treatment. Cancer Treatment Reports, 70, 31–41.
  • MONTGOMERY, J. A., JAmEs, R., MCCALEB, G. S., KIRK, M. C. and JOHNSTON, T. P., 1975, De-composition of N-(2-chloroethyl)-N-nitrosoureas in aqueous media. Journal of Medicinal Chemistry, 18, 568–571.
  • MONTGOMERY, J. A., 1976, Chemistry and structure-activity studies of the nitrosoureas. Cancer Treatment Reports, 60, 651–654.
  • PHILLIPS, R. M., BIBBY, M. C. and DOUBLE, J. A., 1988, In vitro and in vivo responses of a panel of murine colon tumours to tauromustine: a positive correlation. European Journal of Cancer and Clinical Oncology, 24, 1365–1371.
  • POTTER, D. W. and REED, D. J., 1982, Denitrosation of carcinostatic nitrosoureas by purified NADPH cytochrome P-450 reductase and rat liver microsomes to yield nitric oxide under anaerobic conditions. Archives of Biochemistry and Biophysics, 216, 158–169.
  • PRATESI, G. and SAVI, G., 1989, Effects of tauromustine, a water soluble nitrosourea compound, on NMU-1 murine lung tumor. Oncology, 46, 132–135.
  • SEIDEGA RD, J., GRoNQuisT, L. and GUNNARSSON, P. 0., 1990, Metabolism of a novel nitrosourea, tauromustine, in the rat. Biochemical Pharmacology, 39, 1431–1436.
  • Smini, M. T., EVANS, C. G., DOANE -SETZER, P., CASTRO, V. M., TAHIR, M. K. and MANNERVIK, B., 1989, Denitrosation of 1,3-bis(2-chloroethyl)-1-nitrosourea by class mu glutathione transferases and its role in cellular resistance in rat brain tumour cells. Cancer Research, 49, 2621–2625.
  • SMYTH, J. E., HARDCASTLE, J. D., DENTON, G., ALDERSON, D., GRACE, R. H., MANSI, J. L., YOSEF, H. M. A., NORDLE O., LAURI, H. and WÄHLBY, S., 1995, Two phase III trials of tauromustine (TCNU) in advanced colorectal cancer. Annals of Oncology, 6, 948–949.
  • SOUCEK, P. and GUT, I., 1992, Cytochromes P-450 in rats: structures, functions, properties and relevant human forms. Xenobiotica, 22, 83–103.
  • TUVESSON, H., GUNNARSSON, P. 0. and SErDEGA: RD, J., 1993, Measurement and characterisation of the denitrosation of tauromustine in liver cytosol from various species. Carcinogenesis, 14, 1143–1147. WATKINS, P. B., 1994, Noninvasive tests of CYP3A enzymes. Pharmacogenetics, 4, 171–184.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.